Targeted therapies to treat adults with moderate-to-severe plaque psoriasis in the Russian Federation: number needed to treat and cost per responder

Medical Technologies Assessment and Choice (Медицинские технологии Оценка и выбор) ◽

10.17116/medtech20204204158 ◽

2020 ◽

Vol 42 (4) ◽

pp. 58

Author(s):

A.L. Bakulev ◽

V.V. Mladov ◽

V.D. Sokolova ◽

D.G. Tolkacheva

Keyword(s):

Russian Federation ◽

Plaque Psoriasis ◽

Targeted Therapies ◽

Number Needed To Treat ◽

Severe Plaque Psoriasis ◽

The Russian Federation ◽

Cost Per Responder

Download Full-text

Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany

Journal of Dermatological Treatment ◽

10.1080/09546634.2020.1793891 ◽

2020 ◽

pp. 1-7

Author(s):

Matthias Augustin ◽

Daniel Wirth ◽

Jörg Mahlich ◽

Alicia N. Pepper ◽

Cheryl Druchok

Keyword(s):

Plaque Psoriasis ◽

Targeted Therapies ◽

Severe Plaque Psoriasis ◽

Responder Analysis ◽

Cost Per Responder

Download Full-text

PBI15 Biologics to Treat Adults with Active Radiographic Axial Spondyloarthritis in the Russian Federation: Number Needed to Treat and Cost per Responder

Value in Health ◽

10.1016/j.jval.2021.04.086 ◽

2021 ◽

Vol 24 ◽

pp. S17

Author(s):

V. Sokolova ◽

V. Mladov ◽

D. Tolkacheva

Keyword(s):

Russian Federation ◽

Axial Spondyloarthritis ◽

Number Needed To Treat ◽

The Russian Federation ◽

Cost Per Responder

Download Full-text

Number Needed to Treat Among Therapies for Patients with Moderate to Severe Plaque Psoriasis: Clinical Perspective of Results from a Network Meta-Analysis

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.54 ◽

2021 ◽

Vol 5 (6) ◽

pp. s54

Author(s):

C Leonardi ◽

K Fahrbach ◽

B Neupane ◽

A Armstrong ◽

K Gordon ◽

...

Keyword(s):

Plaque Psoriasis ◽

Meta Analysis ◽

Number Needed To Treat ◽

Clinical Perspective ◽

Severe Plaque Psoriasis

N/A

Download Full-text

PSY12 COST PER RESPONDER ANALYSIS OF GUSELKUMAB VERSUS SECUKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS BASED ON THE ECLIPSE TRIAL

Value in Health ◽

10.1016/j.jval.2019.09.2640 ◽

2019 ◽

Vol 22 ◽

pp. S903 ◽

Author(s):

C. Druchok ◽

A.N. Pepper ◽

J. Garside ◽

F. Hassan

Keyword(s):

Plaque Psoriasis ◽

Severe Plaque Psoriasis ◽

Responder Analysis ◽

Cost Per Responder

Download Full-text

PSS17 - COST PER RESPONDER ANALYSIS OF BRODALUMAB COMPARED WITH USTEKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN CANADA

Value in Health ◽

10.1016/j.jval.2018.09.2517 ◽

2018 ◽

Vol 21 ◽

pp. S425

Author(s):

J. Schembri ◽

M. Barbeau ◽

V. Gaudet

Keyword(s):

Plaque Psoriasis ◽

Severe Plaque Psoriasis ◽

Responder Analysis ◽

Cost Per Responder

Download Full-text

Cost per responder for guselkumab versus secukinumab in the United States based on a head-to-head trial of moderate to severe plaque psoriasis

Journal of Dermatological Treatment ◽

10.1080/09546634.2020.1770172 ◽

2020 ◽

pp. 1-7

Author(s):

Amanda Teeple ◽

Timothy Fitzgerald

Keyword(s):

United States ◽

Plaque Psoriasis ◽

The United States ◽

Severe Plaque Psoriasis ◽

Cost Per Responder

Download Full-text

Cost-per-responder analysis of guselkumab versus secukinumab with the use of efficacy results from pivotal clinical trials in patients with moderate to severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.385 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB89

Keyword(s):

Clinical Trials ◽

Plaque Psoriasis ◽

Severe Plaque Psoriasis ◽

Responder Analysis ◽

Cost Per Responder

Download Full-text

PSY103 - MODELLING AVERAGE COST AND COST-PER-RESPONDER FOR BIOLOGICAL TREATMENTS FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS WITH DOSE ESCALATION AND REAL-WORLD DRUG SURVIVAL

Value in Health ◽

10.1016/j.jval.2018.09.2678 ◽

2018 ◽

Vol 21 ◽

pp. S453

Author(s):

F. Ziegler ◽

E. Apol ◽

A. Egeberg

Keyword(s):

Dose Escalation ◽

Plaque Psoriasis ◽

Average Cost ◽

Severe Plaque Psoriasis ◽

Drug Survival ◽

Biological Treatments ◽

Cost Per Responder

Download Full-text

PSS16 - COST PER RESPONDER ANALYSIS OF CALCIPOTRIOL PLUS BETAMETHASONE DIPROPIONATE AEROSOL FOAM VERSUS NON-BIOLOGIC SYSTEMIC THERAPY IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS

Value in Health ◽

10.1016/j.jval.2018.09.2516 ◽

2018 ◽

Vol 21 ◽

pp. S425

Author(s):

L. Becla ◽

J.M. Carrascosa ◽

J.F. Antunes ◽

A.P. Bewley ◽

M. Delgado Perala ◽

...

Keyword(s):

Plaque Psoriasis ◽

Systemic Therapy ◽

Betamethasone Dipropionate ◽

Severe Plaque Psoriasis ◽

Responder Analysis ◽

Cost Per Responder

Download Full-text

Evaluation of biologic therapies for the treatment of moderate-to-severe plaque psoriasis in the brazilian private healthcare system: a Cost Per Responder (CPR) and Treatment Cost Analysis

Jornal de Assistência Farmacêutica e Farmacoeconomia ◽

10.22563/2525-7323.2019.v4.s1.p.117 ◽

2019 ◽

Vol 4 (1) ◽

Keyword(s):

Cost Analysis ◽

Healthcare System ◽

Plaque Psoriasis ◽

Treatment Cost ◽

Biologic Therapies ◽

Severe Plaque Psoriasis ◽

Private Healthcare ◽

System A ◽

Cost Per Responder

Download Full-text